A major new initiative was launched on Tuesday (15 April) by the Wellcome Sanger Institute in collaboration with Pacific ...

Bernstein analyst Eve Burstein lowered the firm’s price target on PacBio (PACB) to $1.50 from $2 and keeps an Outperform rating on the shares.

Rady study uses PacBio long-read sequencing for RFX3 variant in adolescent patient with autism, showcasing clinical genomics ...

Detailed price information for Pacific Biosciences (PACB-Q) from The Globe and Mail including charting and trades.

Detailed price information for Pacific Biosciences (PACB-Q) from The Globe and Mail including charting and trades.

A study has constructed an unprecedented pangenome map of wild and cultivated rice, and decoded the genetic architecture and ...

US sequencing firm PacBio (Nasdaq: PACB) is cutting jobs and reducing spending across its business as it braces for the financial impact of new global tariffs and growing uncertainty around federal ...

Key Insights Given the large stake in the stock by institutions, Pacific Biosciences of California's stock price ...

Around two-thirds of US adults struggle with persistent tummy troubles like gas, bloating and abdominal pain — and few seek medical help.

A major new initiative, launched on 15 April, will map how gene activity shapes the immune system, and could help identify new therapeutic targets for conditions such as Inflammatory Bowel Disease ...

Vietnam is the first stop in a global PRISM conference series, with upcoming events scheduled for Athens (Greece), San ...